Description

1-(8-Amino-7-Chloro-2,3-Dihydrobenzo[B][1,4]Dioxin-5-Yl)Ethanone is a high-purity, advanced pharmaceutical intermediate characterized by its unique benzodioxin core structure. This compound is of significant commercial importance for its role as a critical building block in the synthesis of complex active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and manufacturers in the pharmaceutical and fine chemical industries engaged in the development of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug molecules, particularly those targeting central nervous system (CNS) disorders.
• Agrochemical Research: Used in the development of new herbicides and pesticides due to its heterocyclic benzodioxin scaffold.
• Organic Synthesis Building Block: Serves as a versatile starting material for constructing more complex polycyclic aromatic systems in academic and industrial R&D.
• Ligand and Catalyst Development: The amino and carbonyl functional groups make it suitable for creating novel ligands in coordination chemistry and catalysis.
• Material Science Precursor: Potential use in the synthesis of organic electronic materials and specialty polymers.

Basic Information

Product Name	1-(8-Amino-7-Chloro-2,3-Dihydrobenzo[B][1,4]Dioxin-5-Yl)Ethanone
CAS No.	166816-09-7
Molecular Formula	C10H10ClNO3
Molecular Weight	227.65 g/mol
Synonyms	5-Acetyl-8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin; 7-Chloro-8-amino-2,3-dihydro-1,4-benzodioxin-5-yl methyl ketone; 1-(8-Amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)ethan-1-one; Ethanone, 1-(8-amino-7-chloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-; 166816-09-7; 8-Amino-7-chloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl methyl ketone
EINECS	Contact for details

Quality Control

Our production of 1-(8-Amino-7-Chloro-2,3-Dihydrobenzo[B][1,4]Dioxin-5-Yl)Ethanone adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All material is released with a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support compliance with cGMP and ISO 9001 standards for pharmaceutical intermediates, and specifications can be tailored to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.